Translational Bioinformatics High Impact Factor Journals
As era allows us to take an increasingly more complete look throughout the genome, transcript I, proteome the resulting datasets are an increasing number of excessive-dimensional. This in turn requires a bigger wide variety of samples on the way to achieve the statistical energy needed to come across the real sign. The past decade or so has visible increasingly massive-scale bio-repositories supposed for medical and translational studies everywhere in the global. These projects incorporate both statistics and bio specimens from man or woman sufferers, enabling researchers to reclassify diseases based totally on underlying molecular pathways, as opposed to the macroscopic signs that have been trusted for centuries in defining sickness. Examples are listed those numerous projects contain different fashions of participation, starting from specific knowledgeable consent to use of de-recognized bio specimens and their related scientific
information fromthe knowledgeable consent is the most ethically rigorous model, but additionally the maximum expensive. Using de-diagnosed specimens and facts is greater scalable, and financially possible. However, as entire genomic data are an increasing number of used, it's far not possible to absolutely de-become aware of those data this raises moral troubles regarding affected person privateness and
information sharing.
High Impact List of Articles
-
Bespoke affinity ligands for the purification of therapeutic proteins
Graziella El Khoury*, Basmah Khogeer, Chen Chen, Kheng T Ng, Shaleem I Jacob and Christopher R Lowe
Review Article: Pharmaceutical Bioprocessing
-
Bespoke affinity ligands for the purification of therapeutic proteins
Graziella El Khoury*, Basmah Khogeer, Chen Chen, Kheng T Ng, Shaleem I Jacob and Christopher R Lowe
Review Article: Pharmaceutical Bioprocessing
-
Biopharmaceutical manufacturing and flexible design: what does the future hold?
Joseph McLaughlin, Amit Banerjee
Editorial: Pharmaceutical Bioprocessing
-
Biopharmaceutical manufacturing and flexible design: what does the future hold?
Joseph McLaughlin, Amit Banerjee
Editorial: Pharmaceutical Bioprocessing
-
A high throughput ultra performance size exclusion chromatography assay for the analysis of aggregates and fragments of monoclonal antibodies
Xiaodun Mou*, Xiaoyu Yang, Hong Li, Alexandre Ambrogelly and David J Pollard
Research Article: Pharmaceutical Bioprocessing
-
A high throughput ultra performance size exclusion chromatography assay for the analysis of aggregates and fragments of monoclonal antibodies
Xiaodun Mou*, Xiaoyu Yang, Hong Li, Alexandre Ambrogelly and David J Pollard
Research Article: Pharmaceutical Bioprocessing
-
Study sheds light on nonessential amino acids in cell culture
Jessica Thorne
News and Views: Pharmaceutical Bioprocessing
-
Study sheds light on nonessential amino acids in cell culture
Jessica Thorne
News and Views: Pharmaceutical Bioprocessing
-
Emerging technologies for the integration and intensification of downstream bioprocesses
Roy N D Souza, Ana M Azevedo, M Raquel Aires-Barros, Nika Lendero Krajnc, Petra Kramberger, Maria Laura Carbajal, Mariano Grasselli, Roland Meyer & Marcelo Fernandez-Lahore*
Review Article: Pharmaceutical Bioprocessing
-
Emerging technologies for the integration and intensification of downstream bioprocesses
Roy N D Souza, Ana M Azevedo, M Raquel Aires-Barros, Nika Lendero Krajnc, Petra Kramberger, Maria Laura Carbajal, Mariano Grasselli, Roland Meyer & Marcelo Fernandez-Lahore*
Review Article: Pharmaceutical Bioprocessing
Relevant Topics in Clinical